NM
N-Power Medicine
United States · Healthtech
N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers.
Product and customers
Its prospective external control-arm platform uses trial-grade data from routine care at community oncology sites to create a comparison cohort, helping sponsors evaluate therapies with smaller or faster trials while patients receive treatment close to home. The company reports its NSCLC ProECA program operating across more than 40 sites.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | $32M | Innovatus Capital Partners — ParticipantLabcorp Venture Fund — ParticipantMerck Global Health Innovation Fund — Participant |